Linezolid | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Linezolid
HEALTH CANADA PATENTS

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Linezolid

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

71 API Suppliers, 30 USDMF, 5 JDMF, 20 EU WC, 7 KDMF, 19 NDC API, 47 Listed Suppliers, $ API Reference Price

71 API Suppliers
30 USDMF
5 JDMF
20 EU WC
7 KDMF
19 NDC API
47 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

21 Intermediates Suppliers

21 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

186 FDF Dossiers, 36 FDA Orange Book, 62 Europe, 7 Canada, 21 South Africa, 60 Listed Dossiers

186 FDF Dossiers
36 FDA Orange Book
62 Europe
7 Canada
21 South Africa
60 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 600MG, SOLUTION;INTRAVENOUS - 200MG/100ML (2MG/ML), SOLUTION;INTRAVENOUS - 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - 600MG/300ML (2MG/ML)

TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 600MG
SOLUTION;INTRAVENOUS - 200MG/100ML (2MG/ML)
SOLUTION;INTRAVENOUS - 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INTRAVENOUS - 600MG/300ML (2MG/ML)

RELATED EXCIPIENT COMPANIES

1 Minakem, 4 Rochem International Inc, 17 SPI Pharma, 2 Seqens, 6 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 9 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 14 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 30 BASF, 2 Clariant, 12 Corel Pharma Chem, 6 DFE Pharma, 1 Doshion Polyscience, 1 Finar, 8 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 31 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 19 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 25 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

99 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 51 Direct Compression, 49 Disintegrants & Superdisintegrants, 36 Thickeners and Stabilizers, 34 Granulation, 34 Controlled & Modified Release, 26 Taste Masking, 23 Lubricants & Glidants, 20 Solubilizers, 20 Chewable & Orodispersible Aids, 19 Film Formers & Plasticizers, 18 Co-Processed Excipients, 17 Parenteral, 13 Topical, 9 Rheology Modifiers, 6 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 4 Emulsifying Agents, 2 Surfactant & Foaming Agents

99 Fillers, Diluents & Binders
53 Coating Systems & Additives
51 Direct Compression
49 Disintegrants & Superdisintegrants
36 Thickeners and Stabilizers
34 Granulation
34 Controlled & Modified Release
26 Taste Masking
23 Lubricants & Glidants
20 Solubilizers
20 Chewable & Orodispersible Aids
19 Film Formers & Plasticizers
18 Co-Processed Excipients
17 Parenteral
13 Topical
9 Rheology Modifiers
6 API Stability Enhancers
5 Empty Capsules
4 Vegetarian Capsules
4 Coloring Agents
4 Emulsifying Agents
2 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 44 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
44 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 40 Finished Drug Prices, 8 Annual Reports

3 US Medicaid Prescriptions
40 Finished Drug Prices
8 Annual Reports

MARKET PLACE

43 APIs, 20 FDF Dossiers

43 APIs
20 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 15 Others

1 USP
15 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 798 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Pfizer Canada Inc.

filter Patent Reset all filters

4 All

01 42168560

filter Product Reset all filters

4 All

01 4Linezolid

filter Dosage Reset all filters

4 All

01 1Liquid

02 1Oral Suspension

03 2Tablet

filter Exp Date Reset all filters

4 All

01 42014-08-16

Product Main Page

01

Pfizer Canada Inc.

Linezolid

The Pharmacy Technology

Not Confirmed

Pfizer Canada Inc.

The Pharmacy Technology

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-08-16

Date Granted : 2001-08-14

Brand Name : ZYVOXAM

Patent Number : 2168560

Filing Date : 1994-08-16

Strength per Unit : 400mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-08-16

Date Granted : 2001-08-14

Portfolio PDF

Product Web Link

Digital Content

02

Pfizer Canada Inc.

Linezolid

The Pharmacy Technology

Not Confirmed

Pfizer Canada Inc.

The Pharmacy Technology

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-08-16

Date Granted : 2001-08-14

Brand Name : ZYVOXAM

Patent Number : 2168560

Filing Date : 1994-08-16

Strength per Unit : 600mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-08-16

Date Granted : 2001-08-14

Portfolio PDF

Product Web Link

Digital Content

03

Pfizer Canada Inc.

Linezolid

The Pharmacy Technology

Not Confirmed

Pfizer Canada Inc.

The Pharmacy Technology

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-08-16

Date Granted : 2001-08-14

Brand Name : ZYVOXAM

Patent Number : 2168560

Filing Date : 1994-08-16

Strength per Unit : 2 mg / ml

Dosage Form : Liquid

Human Or VET : Human

Route of Administration : I.V.

Patent Expiration Date : 2014-08-16

Date Granted : 2001-08-14

Portfolio PDF

Product Web Link

Digital Content

04

Pfizer Canada Inc.

Linezolid

The Pharmacy Technology

Not Confirmed

Pfizer Canada Inc.

The Pharmacy Technology

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-08-16

Date Granted : 2001-08-14

Brand Name : ZYVOXAM

Patent Number : 2168560

Filing Date : 1994-08-16

Strength per Unit : 100mg / 5ml

Dosage Form : Oral Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-08-16

Date Granted : 2001-08-14

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?